Table 1. Proportion of antimicrobial non-susceptibility stratified in 5 year intervals.
| Year | Total no. of isolates | Proportion (%) of resistant isolates | ||||||
|---|---|---|---|---|---|---|---|---|
| CH | AMP | TMX | MDR | NAL | CIP | CEPH | ||
| Pre-1991 | 507 | 31.2 | 16.2 | 16.1 | 16.1 | NA | NA | NA |
| 1991–1995 | 2506 | 49.2 | 49.1 | 49.2 | 49.1 | NA | NA | NA |
| 1996–2000 | 2436 | 44.1 | 46 | 45 | 44 | 22 | 12 | 2 |
| 2001–2005 | 4654 | 31 | 35 | 33 | 31 | 50 | 23 | 1 |
| 2006–2010 | 1974 | 19 | 32 | 18 | 18 | 63 | 33 | 1 |
| 2011–2015 | 1756 | 13 | 20 | 18 | 13 | 8 | 63 | 4 |
Table 1 represents the proportions of antimicrobial non-susceptibility stratified in 5- year intervals. These data were pooled from 72 published reports from 1973 to 2017
Abbreviations; CH-Chloramphenicol, AMP-Ampicillin, TMX-Cotrimoxazole, NAL-Nalidixic Acid, CIP-Ciprofloxacin, CEPH-Cephalosporins